Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
18%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
58%
ALSO IN XPH
XPH
57
HOLDINGS
24%
ALSO IN PPH
SECTOR DRIFT (PPH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 23.2% | 2.5% | 2.5% |
|
PFIZER INC | 5.1% | 2.2% | 2.2% |
|
ZOETIS INC | 2.6% | 2.2% | 2.2% |
|
JOHNSON & JOHNSON | 3.3% | 2.0% | 2.0% |
|
MERCK & CO. INC. | 12.6% | 2.0% | 2.0% |
PPH Overweight Relative to XPH
|
ELI LILLY & CO | 20.7% |
|
MERCK & CO. INC. | 10.5% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.4% |
 |
TEVA PHARMACEUTICAL-SP ADR | 4.6% |
|
MCKESSON CORP | 4.6% |
|
CENCORA INC | 4.2% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.2% |
|
ASTRAZENECA PLC-SPONS ADR | 3.8% |
|
ABBVIE INC | 3.7% |
 |
NOVARTIS AG-ADR | 3.7% |
PPH Underweight Relative to XPH
|
VERADERMICS INC | -2.8% |
|
PACIRA PHARMACEUTICALS INC | -2.5% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.5% |
|
MAZE THERAPEUTICS INC | -2.3% |
|
LIGAND PHARMACEUTICALS-CL B | -2.2% |
|
ROYALTY PHARMA PLC CLASS A | -2.2% |
|
SEPTERNA INC | -2.2% |
 |
PERRIGO CO | -2.1% |
|
BIOSANTE PHARMACEUTICALS INC | -2.0% |
|
PRESTIGE BRANDS HOLDINGS INC | -2.0% |